The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)

The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)

The European Anti Cancer Foundation TP53 Trust and the International Clinical Research Organization REDO have invited Researcher Lu Min to explore the feasibility, risk benefit ratio, and open discussion of intermittent low-dose arsenic dosing for the prevention and treatment of p53 congenital mutation related cancers in the patient population

The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)
  • 021-64370045 
  • min.lu@@shsmu.edu.cn
  • No. 197, Ruijin Er Road, Huangpu District, Shanghai, China

The Min Lu Research Group©️Copyright